✦ LIBER ✦

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

✍ Scribed by Piotr Rutkowski, Elżbieta Bylina, Anna Klimczak, Tomasz Świtaj, Sławomir Falkowski, Jacek Kroc, Iwona Ługowska, Magdalena Brzeskwiniewicz, Wojciech Melerowicz, Czesław Osuch, Ewa Mierzejewska, Kacper Wasielewski, Agnieszka Woźniak, Urszula Grzesiakowska, Zbigniew I Nowecki, et al

Book ID: 119897196
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 248 KB
Volume: 12
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-12-107

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regorafenib: A Guide to Its Use in Advan

Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib

✍ Lyseng-Williamson, Katherine A. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 253 KB

212 POSTER A phase II study of the KIT i

212 POSTER A phase II study of the KIT inhibitor XL820 in patients with advanced gastrointestinal stromal tumors (GIST) resistant to or intolerant of imatinib and/or sunitinib

✍ A.J. Wagner; S. Yazji; J.A. Morgan; E. Choy; S. George; M. Hohos; M. O'Mara; G.D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

4526 POSTER Safety profile of single-age

4526 POSTER Safety profile of single-agent sunitinib malate from the French Temporary Authorization for Use program (Cohort ATU) in metastatic renal cell carcinoma (MRCC) after failure of treatment with cytokines and gastrointestinal stromal tumor (GIST) patients after failure of imatinib mesylate treatment

✍ Oudard, S.; Negrier, S.; Ferrero, J.M.; Gravis, G.; Blay, J.Y.; Le Cesne, A.; Kr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB